1. Canada Stocks

  2. •

    Commercial services

  3. •

    Miscellaneous commercial services
NexgenRx Inc.

NexgenRx Inc.

0.44
USD
+0.01
(+2.33%)
0.02EPS
12.78P/E
23.06MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.09
0.08
0.08
0.1
0.09
0.11
0.14
0.16
0.17
0.18
0.2
0.23
0.25
0.26
Basic EPS, GAAP
0.01
-0.01
- -
0.01
-0.01
-0.01
- -
0.03
0.06
- -
-0.01
0.01
0.01
0.04
Free Cash Flow per Basic Share
0.01
-0.01
- -
0.01
-0.01
-0.01
- -
0.02
0.03
0.01
0.01
0.01
0.07
0.04
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
0.01
0.02
0.02
Book Value per Share
- -
-0.01
- -
0.01
0.03
0.03
0.03
0.06
0.11
0.1
0.09
0.08
0.08
0.11
Tangible Book Value per Share
- -
-0.01
- -
0.01
0.02
-0.05
-0.06
-0.03
0.02
0.03
0.02
0.03
0.05
0.08
Basic Weighted Avg Shares
56
56
57
59
60
68
70
70
70
70
71
71
71
73
Sales/Revenue/Turnover
5
4
5
6
6
7
10
11
12
13
14
16
18
19
Operating Margin (%)
14.56
-9.05
-6.99
8.98
-9.34
-7.78
0.98
19.55
18.57
2.25
-1.04
7.27
12.45
18.85
Depreciation Expense
- -
- -
- -
- -
- -
- -
1
1
1
1
1
1
1
1
Net Income, GAAP
1
- -
- -
1
-1
-1
- -
2
4
- -
- -
1
1
3
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
116.66
- -
40.14
33.37
19.71
Profit Margin (%)
12.39
-11.33
-4.01
10.21
-11.04
-9.72
-2.18
19.16
33.93
-0.18
-2.4
3.73
7.19
13.7
Working Capital
- -
- -
- -
- -
1
-1
-3
-1
1
1
1
2
4
6
LT Debt
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
1
2
2
2
6
10
9
8
8
8
9
Return on Invested Capital (%)
267.29
- -
- -
- -
- -
- -
- -
- -
- -
-0.49
- -
8.77
17.41
30.44
Return on Capital (%)
239.55
- -
- -
- -
- -
- -
- -
- -
- -
-0.27
- -
7.75
16.2
29.11
Return on Common Equity (%)
- -
- -
- -
- -
-46.02
-35.56
-10.95
72.8
66.78
-0.29
-7.99
6.92
17.73
37.11

Capital Structure

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
2
2
2
Shares Outstanding
71
71
71
Market Capitalization
27
- -
33

Working Capital

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
32
37
42
Cash, Cash Equivalents & STI
5
5
4
Accounts Receivable, Net
1
1
3
Inventories
- -
- -
- -
Total Current Liabilities
29
32
36
Payables & Accruals
2
1
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-59.76%
10.6%
-0.04%
Free Cash Flow
140.85%
99.94%
456.24%
Net Income, GAAP
-59.89%
239.2%
109.86%
Sales/Revenue/Turnover
14.78%
10.27%
8.84%
Total Cash Common Dividend
- -
144.45%
50.21%

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4
4
4
4
16
2025
4
4
5
4
18
2026
5
5
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.01
2025
0.01
0.01
0.01
- -
0.01
2026
0.02
0.01
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
- -
- -
0.01
2025
- -
0.01
0.01
0.01
0.02
2026
- -
0.01
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Ronald Campbell Loucks
Full Time Employees
20
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
191 The West Mall Toronto ON Canada M9C 5K8
IPO Date
Sep 15, 2006
Website
nexgenrx.com
Similar Companies
PayPal Holdings, Inc. (NASDAQ:PYPL)
Shopify Inc. (NASDAQ:SHOP)
Greenland Mines Ltd (NASDAQ:GRML)
Block, Inc. (NYSE:XYZ)
Netcapital Inc. (NASDAQ:NCPL)
Shopify, Inc. Class A (TSX:SHOP)
Business
NexgenRx Inc. provides third-party administration and software-as-a-service technology solutions for group health-benefit, pension and patient-support programs in Canada. The Company administers, adjudicates and pays prescription drug, dental and extended-health claims on behalf of beneficiaries of health benefit plans sponsored or underwritten by plan sponsors, insurers and other customers. Its principal offerings include NexSys, a rules-based, integrated platform for secure real-time eligibility, enrolment and adjudication of drug, dental and extended-health claims, with front-end, hour-bank, mobile-access and provider-network capabilities; NexAdmin, a benefit-plan administration and self-administration platform that enables sponsors to maintain member information and administer plan operations; NexPension, a multi-employer pension-administration solution for recording and calculating member-group contributions; and NexPSPAssist, a service and claims-adjudication capability designed to help patient support programs optimize delivery for pharmaceutical-manufacturer clients. NexgenRx also provides proprietary claims-processing software, plan-management, enrolment, eligibility, reporting, implementation, operational and related ancillary services. The Company serves plan sponsors, insurers, benefits consultants, insurance brokerages, pharmacy patient-assistance programs, providers, multi-employer union trusts and pharmaceutical companies. NexgenRx began operations in 2003 and is headquartered in Toronto, Ontario. Recent initiatives include continued expansion of client relationships and transaction volumes, investment in digital transformation and process automation, enhancement of its technology platform, and evaluation of practical artificial-intelligence applications through its AI Committee to improve analytics, productivity, customer experience and operating scalability. In August 2026, the Company reported second-quarter revenue growth of 20.8% year over year to C$5.16 million, attributed primarily to higher transaction-fee revenue and continued business expansion, and declared a C$0.005-per-share dividend payable by August 31, 2026.

Company News

Company News APIChatGPT

  • accessnewswire.com

    NexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA Growth

  • accessnewswire.com

    NexgenRx Announces Declaration of Divdend

  • accessnewswire.com

    NexgenRx Announces 2025 Year End Results with Continued Increasing Net Income, EBITDA And Revenue Growth

  • accessnewswire.com

    NexgenRx Announces Declaration of Divdends

  • accessnewswire.com

    NexgenRx Announces Declaration of Dividends

  • accessnewswire.com

    NexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth

  • accessnewswire.com

    NexgenRx Announces Declaration of Dividend

  • accessnewswire.com

    NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA

  • accessnewswire.com

    NexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA

  • accessnewswire.com

    NexgenRx Announces Declaration of Divdend

  • accessnewswire.com

    NexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA

  • accesswire.com

    NexgenRx Announces Third Quarter Results and Declaration of Divdend

  • accesswire.com

    NexgenRX Announces Director Re-Appointment

  • accesswire.com

    NexgenRx Announces New Director

  • accesswire.com

    NexgenRx Announces Second Quarter Results, With Over 19% Revenue Growth and Positive EBITDA

  • accesswire.com

    NexgenRx Announces Share Issuances Under Consulting Agreement

  • accesswire.com

    NexgenRx Announces Declaration of Dividend

  • accesswire.com

    NexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record Earnings

  • accesswire.com

    NexgenRx Announces Annual Meeting Results

  • accesswire.com

    NexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA